Communiqués Panacea Biotec Limited Bombay S.E.

Actions

Marché Fermé - Bombay S.E. 12:03:00 11/09/2026			Varia. 5j.	Varia. 1 janv.
398,05 ^INR	+2,50%		+2,23%	+5,79%

13/08	Panacea Biotec Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
05/08	Panacea Biotec Limited reçoit une lettre d'attribution de l'UNICEF pour la fourniture de vaccins antipoliomyélitiques oraux bivalents d'une valeur de 8,205 millions USD (782,4 millions INR) en 2028	CI

11/02	Panacea Biotec : Unaudited Financial Results for quarter and nine months ended December 31, 2025	PU
29/01	Panacea Biotec : Annual Return for financial year 2024-25	PU
14/11	Panacea Biotec : Unaudited financial results for quarter and half year ended September 30, 2025	PU
08/09/25	Panacea Biotec : Business Responsibility and Sustainability Report for FY 2024-25	PU
08/09/25	Panacea Biotec : AGM Notice Year 2024-25	PU
14/08/25	Panacea Biotec : Unaudited Financial Results for quarter ended June 30, 2025	PU
05/09/24	Panacea Biotec : AGM Notice Year 2023-24	PU
14/08/24	Panacea Biotec : Press Release - Initiation of Phase III Clinical Trial of DengiAll by ICMR and Panacea Biotec	PU
29/05/23	Panacea Biotec : Audited Financial Results for quarter and financial year ended March 31, 2023	PU
30/03/17	Panacea Biotec : Introduces World's First Fully Liquid Hexavalent Combination Vaccine EasySixTM for Six Preventable Diseases	PU
26/12/16	Panacea Biotec : announces Receipt of Establishment Inspection Report (EIR) from USFDA for its pharmaceutical facilities at Baddi	PU
07/08/13	Panacea Biotec Limited : Panacea Biotec Observes Organ Donation Day, Mohan Foundation Organizes Awareness Camp in the Company Premises	PU
21/02/12	Panacea Biotec Limited : Panacea Biotec celebrates 63rd Indian Republic day with launch of “POLPROTEC®” in Nigeria	PU